Yayınlar & Eserler

Yayın Ağı
Makaleler 7
Tümü (7)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (7)
Scopus (5)

1. An objective test to assess upper limb functionality in patients with breast cancer-related lymphedema: investigation of the psychometric properties of the upper limb functional test (ULIFT)

Gultekin S. C., Cakir A. B., Guc Z. G., ÖZALP F. R., KESKİNKILIÇ M., YAVUZŞEN T., et al.
BMC Women's Health , cilt.25, sa.1, 2025 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

2. Self-administered versus lymphedema therapist-administered complex decongestive therapy protocol in breast cancer-related lymphedema: a non-inferiority randomized controlled trial with three-month follow-up

Gultekin S. C., KARADİBAK D., Cakir A. B., Guc Z. G., YAVUZŞEN T.
Breast Cancer Research and Treatment , cilt.212, sa.1, ss.123-138, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

3. The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls

Gultekin S. C., Cakir A. B., Guc Z. G., ÖZALP F. R., KESKİNKILIÇ M., YAVUZŞEN T., et al.
Supportive Care in Cancer , cilt.32, sa.2, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

4. Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

BİLİCİ A., Koca S., Karaagac M., Aydin S. G., Eraslan E., Kaplan M. A., et al.
Journal of Cancer Research and Clinical Oncology , cilt.149, sa.11, ss.8243-8253, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

5. HALP score and GNRI: Simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The Izmir oncology group (IZOG) study

Guc Z. G., Alacacioglu A., Kalender M. E., Oflazoglu U., Unal S., Yildiz Y., et al.
FRONTIERS IN NUTRITION , cilt.9, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

6. Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (>= 75) patients

Alkan A., GÜÇ Z. G., Gurbuz M., ozgun G., Degirmencioglu S., Dogan M., et al.
JOURNAL OF MENS HEALTH , cilt.17, sa.4, ss.128-134, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

7. Chemotoxicity Prediction Models

Guc Z. G., KARAOĞLU A.
TIBBI ONKOLOJI - GERIATRIK ONKOLOJI , ss.54-61, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier
Metrikler

Yayın

7

Yayın (WoS)

7

Yayın (Scopus)

5

Atıf (WoS)

51

H-İndeks (WoS)

3

Atıf (Scopus)

10

H-İndeks (Scopus)

2

Atıf (Scholar)

2

H-İndeks (Scholar)

1

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları